Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Delayed ability to sit, Intellectual disability, Global developmental delay, and Motor delay and others; and very common findings: Delayed speech and language development. 65 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Seizure, Intellectual disability, Small cerebral cortex |
Digestive system | 4 | Gastroesophageal reflux, Constipation, Feeding difficulties |
Head and neck | 4 | Microcephaly, Facial asymmetry, Thin upper lip vermilion |
Eyes | 2 | Strabismus, Ptosis |
Growth and development | 2 | Short stature, Intrauterine growth retardation |
Bones and joints | 2 | Joint hypermobility, Sideways curvature of the spine (scoliosis) |
Heart and blood vessels | 2 | Ventricular septal defect, Atrial septal defect |
Muscles | 1 | Low muscle tone (hypotonia) |
Skin | 1 | Redundant neck skin |
Lungs and breathing | 1 | Central sleep apnea |
To date 43 individuals with CDK13 disorder have been reported [, , , , , ]. The features that occur commonly within the phenotypic spectrum of CDK13 disorder are discussed below; it is likely that our understanding of the phenotypic spectrum will evolve as additional affected individuals are identified. The following are the most common clinical features of CDK13 disorder.
All individuals reported to date have had developmental delay (DD) or intellectual disability (ID), with four reported in the mild range. Forty-one of 42 individuals on whom data were available had a degree of learning disability or DD. One individual was reported with formal IQ testing in the low-normal range.
Source: GeneReviews — "CDK13-Related Disorder"
CDK13 encodes cyclin dependent kinase 13 (1,512 aa). Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Highest expression in Ovary (33.5 TPM) and Uterus (29.4 TPM).
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder is associated with mutations in the CDK13 gene on chromosome 7.
The CDK13 protein participates in CDK12 stimulates expression of DNA repair genes and TP53 Regulates Transcription of DNA Repair Genes pathways.
CDK13 is classified as a druggable target (Druggable Genome, Enzyme, Kinase, Serine Threonine Kinase, and Tumor Suppressor categories) with score 2.1.
The small number of published cases to date limits the statistical power for evaluating genotype-phenotype correlations. A possible genotype-phenotype correlation is the observation that the greater the decrease in total kinase activity the more severe the phenotype .
Source: GeneReviews — "CDK13-Related Disorder"
Penetrance based on 43 individuals reported to date appears to be complete: all reported variants have been de novo and no unaffected individuals with a CDK13 pathogenic variant have been reported.
Source: GeneReviews — "CDK13-Related Disorder"
No formal clinical diagnostic criteria for CDK13 disorder have been published.
CDK13 disorder should be considered in individuals with the following clinical and brain MRI findings.
Clinical findings
Developmental delay / intellectual disability
Structural cardiac defects
Atrial septal defects
Ventricular septal defects
Pulmonary valve abnormalities
Hypoplastic pulmonary artery
Suggestive facial dysmorphisms (See .)
Brain MRI. Nonspecific findings in 15 individuals included the following:
Agenesis/hypogenesis of the corpus callosum (5 individuals)
Aplasia of the cerebellar vermis
Periventricular leukomalacia or periventricular gliosis (3)
Spinal cord syrinx (2)
Cerebellar tonsillar abnormalities (2)
Diminished white matter volume (1)
The diagnosis of ...
Source: GeneReviews — "CDK13-Related Disorder"
Table 2. Disorders with Developmental Delay / Intellectual Disability and other Anomalies to Consider in the Differential Diagnosis of CDK13-Related Disorder
Disorder | Gene(s) | MOI | Clinical Features |
|---|---|---|---|
KAT6B | AD | Congenital heart defects; Agenesis of corpus callosum; Dental anomalies (hypoplastic teeth /or delayed eruption of teeth); Hypotonia | In KAT6B-disorders:; Syndrome-specific facial features; Patellar hypoplasia/agenesis; Flexion contractures at hips/knees; Long thumbs / great toes; Immobile mask-like face In CDK13 disorder:; Sacral vertebral abnormalities; Pulmonary artery hypoplasia; Pulmonary valve abnormalities Kabuki syndrome |
Genetic testing for CDK13 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for congenital heart defects, dysmorphic facial features, and intellectual developmental disorder. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with CDK13 disorder, the evaluations summarized (if not performed as part of the evaluation that led to diagnosis) are recommended. Table 3. Recommended Evaluations for CDK13 Disorder Following Initial Diagnosis
System/Concern | Evaluation | Comment |
|---|---|---|
Constitutional | Assessment of height weight for failure to thrive | — |
Eyes | Ophthalmologic eval for strabismus, nystagmus, /or refractive error | — |
ENT/Mouth | Baseline dental eval for wide-spaced peg-shaped teeth | Referral to orthodontist if significant dental abnormalities |
Cardiovascular | Baseline echocardiogram for structural cardiac anomalies | Gastrointestinal/ Feeding |
Genitourinary | Renal ultrasound | To assess for renal structural abnormalities |
Musculoskeletal |
Source: GeneReviews — "CDK13-Related Disorder"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "CDK13-Related Disorder"
View trials for congenital heart defects, dysmorphic facial features, and intellectual developmental disorder
Table 4. Recommended Surveillance for Individuals with CDK13-Related Disorder
System/Concern | Evaluation | Frequency |
|---|---|---|
Eyes | Ophthalmologic eval | Annually during childhood to monitor for strabismus or refractive errors |
ENT/Mouth | Routine dental/orthodontics | As indicated if dental anomalies are present Cardiovascular |
Feeding | For those w/feeding difficulties: assessment of swallowing, feeding, nutritional status, weight gain | Monthly in 1st few mos of life, then at least yearly during childhood Constipation |
Renal | For those w/renal structural abnormalities | Annual laboratory eval for renal function as indicated |
Musculoskeletal | For those w/spinal abnormalities | Annual monitoring for scoliosis progression For those w/joint contractures |
Neurologic | Monitor treatment effectiveness in those w/seizures. | As indicated if clinical seizure activity is suspected Psychiatric/ |
Behavioral | Behavioral assessment | Annual assessment Miscellaneous/ |
Other | Monitor developmental progress educational needs. | Annual assessment Clinical genetics eval |
Source: GeneReviews — "CDK13-Related Disorder"
Phenotype severity distribution: 5 always present features, 1 very common feature, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital heart defects, dysmorphic facial features, and intellectual developmental disorder.
5 publications have been identified in PubMed for congenital heart defects, dysmorphic facial features, and intellectual developmental disorder. Research spans Case Report / Case Series (60%) and Basic Science / Preclinical (40%).
Fischer J (2025). [PMID: 39800774](https://pubmed.ncbi.nlm.nih.gov/39800774/). *Clinical epigenetics*. [Case Report / Case Series]
Contrò G (2025). [PMID: 39971730](https://pubmed.ncbi.nlm.nih.gov/39971730/). *Clinical genetics*. [Case Report / Case Series]
Waheed-Ullah Q (2025). [PMID: 39556044](https://pubmed.ncbi.nlm.nih.gov/39556044/). *Journal of anatomy*. [Basic Science / Preclinical]
Isa HM (2024). [PMID: 38910624](https://pubmed.ncbi.nlm.nih.gov/38910624/). *Cureus*. [Case Report / Case Series]
Hampl M (2024). [PMID: 38511331](https://pubmed.ncbi.nlm.nih.gov/38511331/). *Disease models & mechanisms*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 11:59 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
KMT2D
XLAD |
Congenital heart defects; Dental anomalies, widely spaced teeth; Sagittal cleft vertebrae; Scoliosis |
In Kabuki syndrome:; Syndrome-specific facial features; Brachydactyly; Ear pits; Coarctation of the aorta In CDK13 disorder:; Pulmonary artery hypoplasia; Pulmonary valve abnormalities Mowat-Wilson syndrome |
ZEB2 | AD | Congenital heart defects incl pulmonary artery involvement; Agenesis or hypogenesis of corpus callosum; Constipation, anal stenosis | In Mowat-Wilson syndrome:; Syndrome-specific facial features; Hirschsprung disease; Axenfeld eye anomaly; Uplifted earlobes; Broad medial eyebrows In CDK13 disorder:; Sacral vertebral abnormalities AD = autosomal dominant; MOI = mode of inheritance; XL = X-linked |
Source: GeneReviews — "CDK13-Related Disorder"
Spinal imaging to evaluate for scoliosis, lordosis, cervical vertebral fusions, sacral abnormalities
Physical exam to evaluate for joint contractures |
Neurologic | Neurologic eval | Brain MRI; EEG if seizure activity is suspected Psychiatric/ |
Behavioral | Neuropsychiatric eval | Screen persons age 12 mos for behavior concerns incl sleep disturbances, ADHD, anxiety, /or traits suggestive of ASD. Miscellaneous/ |
Other | Developmental assessment | To incl motor, speech/language eval, general cognitive, vocational skills Consultation w/clinical geneticist /or genetic counselor |